Sartorius Aktiengesellschaft logo

Sartorius Aktiengesellschaft(OTC) SUVPF

Market Cap$19.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+682%
5 Year-51%
1 Year+8%
1 Month+3%
$277.53
-4.17%
-12.06Today
Sartorius Aktiengesellschaft last closing stock price
MetricPriceDate
Last closeUSD 277.532026-10-09
Sartorius Aktiengesellschaft stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.57%USD 275.962026-09-21
1 month+2.68%USD 270.292026-08-10
3 month+13.83%USD 243.822026-06-18
Year to date+3.62%USD 267.832025-12-22
1 year+7.65%USD 257.812025-10-08
3 year-16.69%USD 333.132023-10-09
5 year-51.41%USD 571.222021-10-07
Since inception+682.28%USD 35.482008-03-05

Sartorius Aktiengesellschaft Financials at a Glance

Market Cap

$19.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€3.58B

Net Income (TTM)

€196.29M

EPS (TTM)

$3.31

P/E Ratio

83.79

Dividend

$0.85

Beta (Volatility)

0.22 (Low)

Price

$277.53

Volume

33

Open

$277.53

Previous Close

$277.53

Daily Range

$277.53 - $277.53

52-Week Range

$233.92 - $312.93

Estimated Earnings Date

Oct 22, 2026

SUVPF News

GettyImages-1134770722

With GE Deal Complete, Danaher Becomes The Leader in Bioprocessing

William AlderJan 29, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sartorius Aktiengesellschaft

Sartorius AG, established in 1870 and based in Göttingen, Germany, is a leading global supplier of innovative bioprocess solutions and laboratory products. The company supports life science research, biopharmaceutical manufacturing, and quality control across various industries worldwide.

Products and Services
  • Advanced analytics tools including biosensors and live-cell analysis platforms
  • Comprehensive cell culture and fermentation solutions with various bioreactors
  • Filtration and separation devices for sterile processing and sample preparation
Growth Outlook
  • Revenue of €910 million in Q2 2026, showing consistent growth
  • Operating income margin improved to 19.5% in Q2 2026
  • Strong demand in biopharmaceuticals drives future expansion opportunities
Financial Highlights
  • Net income of €65.8 million in Q2 2026, reflecting a 7.2% net profit margin
  • Trailing twelve months (TTM) revenue of €3.6 billion, indicating robust performance
  • Current ratio of 1.14, demonstrating solid liquidity position
Sartorius AG operates in the healthcare sector, focusing on medical instruments and supplies. The company has a diverse product portfolio that caters to various aspects of life sciences, including advanced analytics, cell culture, and filtration solutions. Recent financial performance highlights a strong revenue stream, with Q2 2026 revenue reaching €910 million, showcasing the company's ability to capitalize on market demand. The operating income margin has also improved, indicating effective cost management and operational efficiency. The growth outlook remains positive, driven by increasing demand in the biopharmaceutical sector. With a TTM revenue of €3.6 billion, Sartorius AG demonstrates a strong market presence and potential for further expansion. The company's liquidity position, reflected in a current ratio of 1.14, supports its ability to meet short-term obligations while pursuing growth opportunities. Overall, Sartorius AG presents a compelling case for potential investors interested in the life sciences and healthcare sectors.
AI Generated • Sep 21, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

14,279

CEO

Michael Grosse, PhD

Website

www.sartorius.com

Headquarters

Göttingen, NI 37079, DE

SUVPF Financials

Key Financial Metrics (TTM)

Gross Margin

45.71%

Operating Margin

17.68%

Net Income Margin

4.79%

Return on Equity

6.28%

Return on Capital

9.32%

Return on Assets

1.79%

Earnings Yield

1.19%

Dividend Yield

0.31%

Payout Ratio

29.64%

Stock Overview

Market Cap

$19.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

69.05M

Volume

33

Avg. Volume

5.723

Financials (TTM)

Gross Profit

€1.64B

Operating Income

€633.82M

EBITDA

€1.05B

Operating Cash Flow

€735.09M

Capital Expenditure

-€442.24M

Free Cash Flow

€293.01M

Cash & ST Invst.

€306.90M

Total Debt

€4.05B

Sartorius Aktiengesellschaft Performance Analysis

Sartorius Aktiengesellschaft annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 4,387,502,4807.6%
20232023-12-31EUR 3,671,144,253-16.3%
20242024-12-31EUR 3,656,871,940-0.4%
20252025-12-31EUR 3,993,021,6479.2%
Sartorius Aktiengesellschaft sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-4.5%
Q42025-12-319.8%
Q12026-03-31-2.7%
Q22026-06-300.9%
Sartorius Aktiengesellschaft annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 10.4289.1%
20232023-12-31EUR 3.25-68.8%
20242024-12-31EUR 1.32-59.5%
20252025-12-31EUR 2.5392.2%
Sartorius Aktiengesellschaft sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3036.2%
Q42025-12-31-32.8%
Q12026-03-3190.7%
Q22026-06-3015.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€910.44M

+3.0%

Gross Profit

€432.45M

+3.9%

Gross Margin

47.50%

N/A

Market Cap

$19.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.36M

N/A

Employees

14,042

N/A

Net Income

€65.80M

+102.5%

EBITDA

€280.93M

+19.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€306.90M

-64.8%

Total Debt

€4.05B

-13.0%

Accounts Receivable

€305.90M

-2.4%

Inventory

€831.90M

+4.3%

Long Term Debt

€3.65B

-10.8%

Short Term Debt

€403.90M

-28.8%

Return on Assets

1.79%

N/A

Return on Invested Capital

7.76%

N/A

Free Cash Flow

€92.10M

+42.1%

Operating Cash Flow

€175.50M

+16.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WSTWest Pharmaceutical Services, Inc.
$374.65+0.76%
TECHBio-Techne Corporation
$72.50+0.03%
AVTRAvantor, Inc.
$15.70+0.96%
RGENRepligen Corporation
$178.20+1.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$221.30-3.16%
BACBank of America
$51.39-4.76%
CRWVCoreWeave
$65.78-15.46%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%

Questions About SUVPF

What is the current price of Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft is trading at $277.53 per share.

What is the 52-week range for Sartorius Aktiengesellschaft?

Over the past 52 weeks, Sartorius Aktiengesellschaft has traded between $233.92 and $312.93.

How much debt does Sartorius Aktiengesellschaft have?

As of the most recent reporting period, Sartorius Aktiengesellschaft reported total debt of €4.63B.

How much cash does Sartorius Aktiengesellschaft have on hand?

Sartorius Aktiengesellschaft reported €332.70M in cash and cash equivalents in its most recent financial results.

What is Sartorius Aktiengesellschaft’s dividend yield?

Sartorius Aktiengesellschaft currently has a dividend yield of 0.31%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services